<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733232/" ref="ordinalpos=299&amp;ncbi_uid=5165999&amp;link_uid=PMC3733232" image-link="/pmc/articles/PMC3733232/figure/F1/" class="imagepopup">Figure 1. Schematic diagram of transforming growth factor-β (TGFβ) <span class="highlight" style="background-color:">signaling</span> and regulation.  From: TGF?-mediated <span class="highlight" style="background-color:">signaling</span> and transcriptional regulation in pancreatic development and cancer. </a></div><br /><div class="p4l_captionBody">The signaling pathway includes two types of membrane Ser/Thr receptor kinases (TβR-I and TβR-II), the receptor Smads2/3, the co-Smad4, the inhibitory Smad7 and nuclear partner proteins (eg, DNA-binding factors). The Smad signaling is negatively regulated by Smad7, which itself can be induced by several crosstalks, including epidermal growth factor signaling and NFkB.</div></div>